-
Mashup Score: 0
With or without US federal regulation, CBD companies should provide consumers with more transparent information about their products.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 9
This study assesses the actual measured quantities of melatonin and cannabidiol (CBD) in products marketed and sold in the US as melatonin gummies compared with the quantities declared on their labels.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Study assesses the actual measured quantities of #melatonin and #cannabidiol (#CBD) in products marketed and sold in the US as melatonin gummies compared with the quantities declared on their labels. https://t.co/dEbmxTmaNq
-
-
Mashup Score: 1Adverse Events of Cannabidiol Use in Patients With Epilepsy - 1 year(s) ago
This systematic review and meta-analysis investigates the frequency and risk of developing adverse events from cannabidiol use in patients with epilepsy.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Meta-analysis: #Cannabidiol treatment for patients with #epilepsy was associated with the development of several types of adverse events. https://t.co/HZTrk9DGRR
-
-
Mashup Score: 0The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents - 1 year(s) ago
Adolescents may respond differently to cannabis than adults, yet no previous functional magnetic resonance imaging study has examined acute cannabis e…
Source: www.sciencedirect.comCategories: Addiction Medicine, Latest HeadlinesTweet-
The Effects of Acute #Cannabis With and Without #Cannabidiol on Neural Reward Anticipation in Adults and Adolescents https://t.co/QOmNP3IbYA https://t.co/fHdvVtCDuu
-
-
Mashup Score: 2Cannabidiol for Absence Epilepsy: More to Learn - 1 year(s) ago
Andrew N. Wilner, MD, and Selim Benbadis, MD, discuss cannabidiol for absence epilepsy.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
.@drwilner and Selim Benbadis, MD, discuss #cannabidiol for absence #epilepsy. #CBD #NeuroTwitter https://t.co/SXYPmEZ428 https://t.co/cxwvzreHKW
-
-
Mashup Score: 0
Investigators conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the impact of cannabinoids on peripheral neuropathic pain.
Source: Clinical Pain AdvisorCategories: Healthcare Professionals, Latest HeadlinesTweet-
Study Shows No Benefit With #CBD, #THC for Peripheral #NeuropathicPain https://t.co/rwdBYETQCG #RCT #clinicaltrial #cannabinoid Oral capsules of .. (THC), #cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment https://t.co/epZn3RMgAG
-
-
Mashup Score: 1
Investigators sought to determine the impact of placebo on pain response in studies evaluating cannabinoids and cannabis-based products.
Source: Clinical Pain AdvisorCategories: Healthcare Professionals, Latest HeadlinesTweet-
ICYMI: #Placebo Has Significant #Pain Reduction Effect in #Cannabinoid Clinical Trials https://t.co/GVp9xEGZXP #Cannabis #cannabidiol #CBD https://t.co/92xto0wxgj Results are not surprising, given media attention, desperation, other factors. Didn't work for me! #neuropathicpain https://t.co/6wqVQWh91g
-
-
Mashup Score: 11
Objectives. To use crowdfunding campaigns to better understand how cannabidiol (CBD) is represented (and misrepresented) as cancer-related care. Methods. We analyzed CBD-related crowdfunding campaigns (n = 155) created between January 2017 and May 2019 in multiple countries on GoFundme.com. Results. More than 81.9% of campaigns fundraised CBD for curative or life-prolonging reasons, and 25.2%…
Categories: Healthcare Professionals, Latest HeadlinesTweet-
Misinformation on every platform. Our study on #CBD bunk: Crowdfunding #Cannabidiol for Cancer: Hype & #Misinformation on #GoFundMe https://t.co/R8aFFnhzle with @marco_zenone @jeremycsnyder "Misinformation around CBD for cancer is widespread on medical crowdfunding campaigns."
-
-
Mashup Score: 0Building a better painkiller - 2 year(s) ago
On a quest to develop more effective pain medicines, scientists are studying how CBD inhibits pain-sensing neurons
Source: EurekAlert!Categories: Healthcare Professionals, Latest HeadlinesTweet-
Building a better #painkiller https://t.co/G25Zt0PBfh via @EurekAlert @HarvardMed #chronicpain #cannabidiol #ionchannels #pain "it is unlikely that #CBD itself will be useful as a painkiller." So much for the anecdotal patient reports and the $$$ being siphoned off them.
-
-
Mashup Score: 0Cannabis-Derived Oromucosal Spray Misses in MS Spasticity Trial - 2 year(s) ago
The RELEASE MSS1 trial included adults with a confirmed diagnosis of any disease subtype of multiple sclerosis.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This investigative treatment contains delta-9-tetrahydrocannabinol, the main psychoactive ingredient of marijuana. #MS #Cannabidiol https://t.co/6Pg347goxw
-
In the United States, there are still no clear regulations for managing the quality of hemp-derived #cannabidiol products, said Bharat Ayyar, CEO of Sunsoil, in an interview with Pharmacy Times. #CBD Read More: https://t.co/lw5HffK65s